ISSN:
3108-2084 (Online)
DOI Prefix (Crossref): 10.67238
Nanomedicine applies nanoscale materials and technologies to the prevention, diagnosis, and treatment of diseases, offering transformative advancements in modern healthcare. By leveraging the unique properties of nanoparticles—such as high surface area, controlled drug release, and targeted delivery—nanomedicine enhances the precision and effectiveness of therapeutic interventions. Key applications include targeted drug delivery systems that minimize side effects, nanosensors for early disease detection, nanocarriers for gene therapy, and nanoparticle-enhanced imaging techniques such as MRI and PET. In oncology, nanomedicine enables the delivery of chemotherapeutic agents directly to tumor cells, improving treatment efficacy while reducing systemic toxicity. Additionally, developments in nanovaccines and antimicrobial nanomaterials are addressing infectious diseases and antibiotic resistance. As clinical translation advances, nanomedicine holds significant promise for personalized medicine, regenerative therapies, and minimally invasive diagnostics, shaping the future of patient-centered care.
| Stage 1 |
Initial Quality & Plagiarism Check The manuscript is reviewed for journal scope, basic submission requirements, ethical compliance, and similarity/plagiarism concerns. |
| Stage 2 |
Editorial Assessment & Peer Review Manuscripts that pass the initial screening undergo editorial assessment and independent peer review in accordance with the journal's peer-review policy. |
| Stage 3 |
Revision & Editorial Decision Authors may be requested to revise their manuscript based on reviewer and editor comments. A final editorial decision is made after the required review and revision stages are completed. |
| Stage 4 |
Production & Publication Accepted manuscripts proceed to production, author proofing, final quality checks, and online publication. |
| English | Publication Language |
| Single-Blind | Peer-Review Model |
| 17% | Acceptance Rate |
| <18% | Similarity Screening Guideline |
| Open Access | Access Model |
All manuscripts undergo editorial assessment and originality screening as part of the journal's evaluation process. The acceptance rate shown is based on journal-level editorial data and may change over time. Similarity reports are assessed editorially and are not interpreted solely on the basis of a numerical similarity score.
